key: cord-0942580-1u6g96db
authors: Portela Dias, J.; Andrade, A.; Costa, P.; Coroado, M.; Gonçalves, D.; Braga, A.; Braga, J.
title: 205 Sars-cov-2 reinfection in pregnancy – A case report
date: 2022-03-31
journal: European Journal of Obstetrics & Gynecology and Reproductive Biology
DOI: 10.1016/j.ejogrb.2021.11.066
sha: 13b06e09f81f965913424e6ee216e4a172c3c70e
doc_id: 942580
cord_uid: 1u6g96db

nan

and urogenital anomalies. Although phenotypes cannot be identified prenatally, genetic diagnosis is possible after identification of ultrasound fetal anomalies, which include growth retardation, cardiac malformations and other structural anomalies. This case aims to illustrate the importance of ultrasound findings in prenatal diagnosis. Methods: Case report. Results: A 24 years old primigravida, melanodermic, with no relevant medical history, was referred to an obstetric consultation at 34 weeks of gestation, after a second and third trimester routine ultrasounds that revealed a severe unilateral ventriculomegaly (posteriorly confirmed by magnetic resonance imaging). Furthermore, at 35 weeks a diagnosis of fetal growth retardation (percentile 2.1 with normal flow measurements) and oligohydramnios was made. Fetal karyotype study revealed 1p36 syndrome and gain of genetic material on chromosome 22; mother karyotype study revealed a balanced translocation between chromosomes 1 and 22. Caesarean delivery occurred at 36 weeks and 6 days without complications, Apgar score 8/8/9 and birth weight of 1970g. The infant, currently 2 years old, has a very guarded prognosis and multiple comorbidities: epilepsy, severe development delay, severe hydrocephalus, bilateral congenital vertical talus, congenital cataract, hearing loss, Ebstein anomaly and interventricular communication. Management includes cognitive and motor rehabilitation programs, antiepileptic drugs and surgical interventions as needed. Conclusions: Pre-natal presentation of 1p36 deletion syndrome is quite variable and may include early miscarriage, morphologic anomalies and fetal growth retardation later in the pregnancy. Therefore more studies are needed to clarify the key fetal ultrasound findings of this syndrome. http://dx.doi.org/10.1016/j.ejogrb.2021.11.065

Introduction and aims of the study: SARS-CoV-2 was identified for the first time in December 2019 in Wuhan, China. The literature and existing data are still scarce about the SARS-CoV-2 impact on pregnancy. Initially, it was generally assumed that once infected, individuals mounted immune response to prevent a second infection; however, cases of reinfection have been reported worldwide. Methods: We report a case of reinfection with the SARS-CoV-2 virus during pregnancy, based on the clinical records and literature review. Results and discussion: 37-year-old woman, asthmatic, presents with fever and myalgia at 19 weeks of gestation. A nasopharyngeal swab was done, and the RT-PCR test for SARS-CoV-2 came positive. She started prophylactic enoxaparin and quarantined for 11 days, until meeting clinical criteria for discharge. The pregnancy was subsequently uncomplicated. At 39 weeks of pregnancy, 20 weeks after her first SARS-CoV-2 infection, she went into labor and was retested for SARS-CoV-2 RNA at admission. She was found to be positive, although she was asymptomatic for COVID-19. She had an eutocic delivery, resulting in a healthy male neonate weighing 3420g. The neonate tested negative twice for SARS-CoV-2 RNA. The woman remained asymptomatic and was discharged 48 hours after delivery, with indication to remain in isolation. Conclusions: SARS-CoV-2 reinfection is known to be possible, although there are very few cases reported during pregnancy. Pregnant women are at risk of more severe disease and there are also reports of vertical infection to the newborns. This report raises the awareness for the need to maintain social distancing and individual protection measures even after a confirmed infection. Introduction and aims: Malaria is the most important parasitic disease of humans, causing 10000 deaths of pregnant women each year. Pregnant women experience more severe disease with anemia, fever, preterm birth, fetal growth restriction, congenital infection and death of mother and/or fetus. One of the unique features of malaria in pregnancy is the ability of Plasmodium falciparum-parasitized erythrocytes to sequester within the intervillous space of the placenta. We intend to raise awareness to the diagnosis of malaria in pregnancy and its complications in pregnancy. Methods: We describe a case of placental malaria with maternal and fetal complications. Results: A 38-years-old multipara, living in Angola until two weeks before the admission at our hospital, had a complicated pregnancy with gestational hypertension, and started at 26 weeks with fever, fatigue, myalgias and back pain. Blood tests showed anemia (Hb 9,2g/dL) and high C-reactive protein (6 mg/L) and leukocyturia. She was hospitalized and started empiric antibiotics to the suspicion of acute pyelonephritis, but she had a clinical deterioration with persistent fever, pancytopenia, hypotension, severe oligoamnios and decreased fetal movements. The peripheral blood smear showed Plasmodium falciparum with 3% of erythrocytes parasitized. It was decided an urgent cesarean section at 27 weeks; a female fetus was born with 876gr (10 th ), Apgar score 3/5/7, without congenital malaria. The mother was transferred to the intensive care for four days and medicated with quinine and doxycycline during 7 days with a positive response. The histological examination of the placenta illustrates multiple Plasmodium spp intra-erythrocytes, areas of stroma edema and lesions of mild chorioamnionitis. Conclusions: We illustrate a case of malaria in pregnancy with severe complications: maternal pancytopenia, intensive care and preterm birth. The diagnosis of malaria, through peripheral blood smears, should be considered in any febrile pregnant woman who has traveled to or resided in an endemic region.

Introduction and aims: Placental mesenchymal dysplasia (PMD) is a rare vascular and connective placental anomaly characterized by an enlarged and thickened placenta with multiple hypoechoic cystic spaces, which is often associated with severe fetal and/or maternal complications. We intend to discuss some severe complications of PMD to alert health professionals to the importance of this rare disease. Methods: We describe a case of undiagnosed PMD with several maternal and fetal complications. Results: A 23-years-old healthy 

Placental mesenchymal dysplasia: A case report with bad outcome